Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/125261
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFernández, Belén-
dc.contributor.authorFerrer, Isidro (Ferrer Abizanda)-
dc.contributor.authorGil, Fernando-
dc.contributor.authorHilfiker, Sabine-
dc.date.accessioned2018-10-10T12:33:34Z-
dc.date.available2018-10-10T12:33:34Z-
dc.date.issued2017-01-01-
dc.identifier.urihttp://hdl.handle.net/2445/125261-
dc.description.abstractIron levels in the healthy human brain are known to be high in certain areas such as the substantia nigra (SN), and increase further with age. In addition, there is some evidence for a further increase in iron load in the SN of Parkinsons disease (PD) patients as compared to controls, which correlates with motor disability. Here, we have analyzed total iron levels in cells as well as mouse and human brain samples by atomic absorption spectroscopy (AAS). Our data indicate that iron load is more pronounced in cells with dopaminergic features. Moreover, region-specific differences in iron load reflecting those in the human brain were detected in rodent brains as well. Whilst altered iron load was not observed in other regions also affected in PD patients, we report a significant increase in iron load in the SN of Lewy body disease patients as compared to Alzheimers disease (AD) patients or controls, which correlates with neurodegeneration in this brain area.-
dc.format.extent6 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.toxrep.2017.03.005-
dc.relation.ispartofToxicology Reports, 2017, vol. 4, p. 188-193-
dc.relation.urihttps://doi.org/10.1016/j.toxrep.2017.03.005-
dc.rightscc by-nc-nd (c) Fernández et al., 2017-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationCervell-
dc.subject.classificationFerro-
dc.subject.classificationDemència amb cossos de Lewy-
dc.subject.classificationMalaltia de Parkinson-
dc.subject.otherBrain-
dc.subject.otherIron-
dc.subject.otherLewy body dementia-
dc.subject.otherParkinson's disease-
dc.titleBiomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec690166-
dc.date.updated2018-07-24T12:12:19Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid28529891-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Patologia i Terapèutica Experimental)

Files in This Item:
File Description SizeFormat 
690166.pdf533.47 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons